Skip to content
GenoLensGenoLens

CREB3L1

Chr 11p11.2

cAMP responsive element binding protein 3 like 1

Aliases:
OASIS
MANE:
ENST00000621158.5

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Osteogenesis imperfecta

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • osteogenesis imperfecta

    0.55
  • hypertensive disorder

    0.38
  • lung carcinoma

    0.37
  • synovial sarcoma

    0.37
  • undifferentiated pleomorphic sarcoma

    0.37
  • osteogenesis imperfecta type 3

    0.37
  • ovarian endometrioid adenocarcinoma with squamous differentiation

    0.37
  • lipoma

    0.37
  • breast ductal adenocarcinoma

    0.37
  • congenital fibrosarcoma

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Cyclic AMP-responsive element-binding protein 3-like protein 1

Precursor of the transcription factor form (Processed cyclic AMP-responsive element-binding protein 3-like protein 1), which is embedded in the endoplasmic reticulum membrane with N-terminal DNA-binding and transcription activation domains oriented toward the cytosolic face of the membrane (PubMed:12054625, PubMed:16417584, PubMed:25310401). In response to ER stress or DNA damage, transported to the Golgi, where it is cleaved in a site-specific manner by resident proteases S1P/MBTPS1 and S2P/MBTPS2. The released N-terminal cytosolic domain is translocated to the nucleus where it activates transcription of specific target genes involved in the cell-cycle progression inhibition (PubMed:12054625, PubMed:21767813, PubMed:25310401)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.